Filing Details
- Accession Number:
- 0001209191-22-055063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-01 17:00:14
- Reporting Period:
- 2022-10-28
- Accepted Time:
- 2022-11-01 17:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | Pharmaceutical Preparations (2834) | 824800132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864116 | Andrew Bellinger | C/O Verve Therapeutics, Inc. 201 Brookline Avenue, Suite 601 Boston MA 02215 | Cso & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-28 | 10,000 | $1.48 | 16,629 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-28 | 10,000 | $39.90 | 6,629 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-10-28 | 10,000 | $0.00 | 10,000 | $1.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 86,995 | 2029-09-16 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2022.
- The remaining shares underlying this option, which was granted on September 17, 2019, vest in equal monthly installments until October 1, 2023.
Billionaire Hedge Funds
